Raymond James & Associates Integra Lifesciences Holdings Corp Transaction History
Raymond James & Associates
- $161 Billion
- Q3 2024
A detailed history of Raymond James & Associates transactions in Integra Lifesciences Holdings Corp stock. As of the latest transaction made, Raymond James & Associates holds 47,750 shares of IART stock, worth $650,355. This represents 0.0% of its overall portfolio holdings.
Number of Shares
47,750
Previous 157,055
69.6%
Holding current value
$650,355
Previous $4.58 Million
81.05%
% of portfolio
0.0%
Previous 0.0%
Shares
30 transactions
Others Institutions Holding IART
# of Institutions
235Shares Held
78.8MCall Options Held
24.6KPut Options Held
0-
Black Rock Inc. New York, NY11.3MShares$153 Million0.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA7.58MShares$103 Million0.0% of portfolio
-
Rubric Capital Management LP New York, NY7.35MShares$100 Million2.08% of portfolio
-
Eaton Vance Management Boston, MA4.22MShares$57.4 Million0.26% of portfolio
-
Morgan Stanley New York, NY3.93MShares$53.6 Million0.0% of portfolio
About INTEGRA LIFESCIENCES HOLDINGS CORP
- Ticker IART
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 83,518,200
- Market Cap $1.14B
- Description
- Integra LifeSciences Holdings Corporation develops, manufactures, and markets surgical implants and medical instruments for use in neurosurgery, extremity reconstruction, and general surgery. It operates in two segments, Codman Specialty Surgical and Tissue Technologies. The company offers neurosurgery and neuro critical care products, including...